Teton Advisors, Inc. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Teton Advisors, Inc. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2021$456,000
-3.0%
337,0000.0%0.06%
-1.5%
Q4 2020$470,000
+1.5%
337,0000.0%0.07%
-17.5%
Q3 2020$463,000
-17.3%
337,0000.0%0.08%
-11.1%
Q2 2020$560,000
+29.6%
337,0000.0%0.09%
+28.6%
Q1 2020$432,000
-16.3%
337,0000.0%0.07%
+34.6%
Q4 2019$516,000
+11.9%
337,0000.0%0.05%
+10.6%
Q3 2019$461,000
+4.3%
337,0000.0%0.05%
+9.3%
Q2 2019$442,000
-2.9%
337,0000.0%0.04%
-4.4%
Q1 2019$455,000
+60.8%
337,000
+42.2%
0.04%
+45.2%
Q4 2018$283,000
-30.0%
237,0000.0%0.03%
-11.4%
Q3 2018$404,000
+18.1%
237,0000.0%0.04%
+16.7%
Q2 2018$342,000237,0000.03%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2019
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders